ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 135 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $22,000 | -12.0% | 15,450 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $25,000 | -3.8% | 15,450 | -11.5% | 0.00% | 0.0% |
Q3 2016 | $26,000 | -23.5% | 17,450 | -16.9% | 0.00% | -33.3% |
Q2 2016 | $34,000 | 0.0% | 21,000 | -2.9% | 0.00% | 0.0% |
Q1 2016 | $34,000 | -10.5% | 21,633 | -9.5% | 0.00% | 0.0% |
Q4 2015 | $38,000 | -56.3% | 23,900 | -39.6% | 0.00% | -62.5% |
Q3 2015 | $87,000 | -57.1% | 39,600 | -34.1% | 0.01% | -55.6% |
Q2 2015 | $203,000 | -23.7% | 60,100 | -4.8% | 0.02% | -25.0% |
Q1 2015 | $266,000 | -99.9% | 63,100 | +2.3% | 0.02% | -7.7% |
Q4 2014 | $360,945,000 | +120617.4% | 61,700 | -16.0% | 0.03% | +13.0% |
Q3 2014 | $299,000 | -31.4% | 73,450 | -1.3% | 0.02% | -32.4% |
Q2 2014 | $436,000 | -12.4% | 74,400 | -0.3% | 0.03% | -20.9% |
Q1 2014 | $498,000 | +27.0% | 74,650 | +13.1% | 0.04% | +22.9% |
Q4 2013 | $392,000 | +28.5% | 66,000 | +11.8% | 0.04% | +16.7% |
Q3 2013 | $305,000 | -30.0% | 59,050 | +5.3% | 0.03% | -44.4% |
Q2 2013 | $436,000 | – | 56,100 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 9,750,000 | $18,623,000 | 1.60% |
DAFNA Capital Management LLC | 381,600 | $729,000 | 0.72% |
SENZAR ASSET MANAGEMENT, LLC | 1,766,991 | $3,374,953,000 | 0.49% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,640,877 | $8,864,000 | 0.34% |
Lyons Wealth Management, LLC. | 56,665 | $110,000 | 0.14% |
FEDERATED HERMES, INC. | 5,648,920 | $10,789,000 | 0.04% |
WELLINGTON MANAGEMENT GROUP LLP | 33,909,459 | $64,767,000 | 0.02% |
Cubist Systematic Strategies, LLC | 185,166 | $354,000 | 0.02% |
GAM Holding AG | 523,164 | $997,000 | 0.02% |
STEVENS CAPITAL MANAGEMENT LP | 191,236 | $365,000 | 0.02% |